Biotech news
Pharma
US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche. 21 May 2019
Americas
3D-printed organs and tissues are now a reality, but questions remain over their patentability, says Gabriel Di Blasi of Di Blasi, Parente & Associados. 20 May 2019
Americas
Brazil’s patent law does not allow methods of treatment to be patented, but there are other means of getting protection, according to Kene Gallois and Samantha Salim of Daniel Law. 20 May 2019
Asia
An upcoming case on the patent eligibility of genetically modified seed in India will have far-reaching ramifications, as Archana Shankar and Gitika Suri of Anand & Anand explain. 20 May 2019
Americas
It is challenging but not impossible to protect software innovations in Mexico, according to Alejandro Moreno Hernández of Uhthoff, Gomez Vega & Uhthoff. 20 May 2019
Americas
Alphabet-owned GV has invested in Verve Therapeutics, a cardiovascular company developing gene editing therapies aiming to permanently reduce the risk of coronary artery disease. 14 May 2019
Americas
The Food and Drug Administration has issued final guidance on the pathway for ‘interchangeable’ biosimilar products, in a bid to promote competition in the biologics market. 13 May 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, May 8, rejected an appeal from Amgen in patent litigation relating to two Sandoz biosimilars. 9 May 2019
Biotech
Danish pharmaceutical company Lundbeck will acquire Abide Therapeutics, it has been announced. 8 May 2019
Biotech
A former scientist at Bayer CropScience shared confidential information with his new employer, which was used to develop commercial biopesticide products, according to a claim filed by the agricultural company. 8 May 2019